| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/23/2014 | WO2014013027A1 Medicament for wound treatment |
| 01/23/2014 | WO2014012559A1 Granulocyte-macrophage colony-stimulating factor for the treatment of bronchial asthma |
| 01/23/2014 | WO2014012399A1 Recombinational lucid ganoderma immunomodulatory protein methoxypolyethyleneglycol propionic acid succinimidyl ester modifier, preparation method and use |
| 01/23/2014 | WO2014012312A1 Anti-inflammatory lipopeptide and preparing method and application thereof |
| 01/23/2014 | WO2014012147A1 Method of diagnosis and treatment |
| 01/23/2014 | WO2013184962A4 Chimeric fibroblast growth factor 19 proteins and methods of use |
| 01/23/2014 | WO2013177588A8 C1q/TNF-RELATED PROTEIN-9 (CTRP9) AND USE IN PREVENTION AND TREATMENT OF METABOLIC DISORDERS |
| 01/23/2014 | WO2013175494A3 Controlled release pharmaceutical formulations of direct thrombin inhibitors |
| 01/23/2014 | WO2013088369A3 Use of the protein mmp-12 in the prevention and/or treatment of greasy skin and/or greasy-prone skin |
| 01/23/2014 | WO2012166554A8 Extracellular matrix material conduits and methods of making and using same |
| 01/23/2014 | WO2012164488A3 New cosmetic or dermopharmaceutical topical use of a mixture of a ghk tripeptide and gqpr tetrapeptide |
| 01/23/2014 | US20140025814 System and Method for Monitoring and Analyzing Internet Traffic |
| 01/23/2014 | US20140024701 Compositions and Methods for Treating Neurogenic Disorders of the Pelvic Floor |
| 01/23/2014 | US20140024604 Glycopeptide phosphonate derivatives |
| 01/23/2014 | US20140024599 Methods and compositions for treatment of disease or injury of the nervous system |
| 01/23/2014 | US20140024598 Methods and compositions for preserving retinal ganglion cells |
| 01/23/2014 | US20140024597 Intranasal delivery of cell permeant therapeutics |
| 01/23/2014 | US20140024596 Disease inhibiting agent |
| 01/23/2014 | US20140024594 Compositions and methods for the treatment and prevention of cardiac ischemic injury |
| 01/23/2014 | US20140024592 Modified Relaxin Polypeptides |
| 01/23/2014 | US20140024589 Follicle Stimulating Hormone Superagonists |
| 01/23/2014 | US20140024588 Method for inducing sustained immune response |
| 01/23/2014 | US20140024586 Use of an fgf-21 compound and a glp-1 compound for the treatment of obesity |
| 01/23/2014 | US20140024585 Composition for the therapy of diabetes mellitus and adiposity |
| 01/23/2014 | US20140024582 Stable insulin formulations and methods of making and using thereof |
| 01/23/2014 | US20140024579 Methods for treating hcv |
| 01/23/2014 | US20140023729 Nutritional supplement for disinhibiting therapy of psychiatric patients |
| 01/23/2014 | US20140023714 Hemostatic compositions |
| 01/23/2014 | US20140023701 Method and Composition for Ameliorating the Effects tor a Subject Exposed to Radiation or Other Sources of Oxidative Stress |
| 01/23/2014 | US20140023700 Cyclic peptide and conjugate thereof for binding to keratinocytes |
| 01/23/2014 | US20140023696 Treatment for idiopathic pulmonary fibrosis |
| 01/23/2014 | US20140023666 Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof |
| 01/23/2014 | US20140023633 Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function |
| 01/23/2014 | US20140023631 Methods of treating anemia and red blood cell dysfunction with lecithin cholesterol acyltransferase |
| 01/23/2014 | US20140023616 Macrocyclic inhibitors of flaviviridae viruses |
| 01/23/2014 | US20140023612 Granulocyte-Macrophage Colony Stimulating Factor for Enhancing Pulmonary Host Defense in Acute and Chronic Radiation Syndrome, Therapeutic Radiation Intervention and Cancer Therapy |
| 01/23/2014 | US20140023597 Antimicrobial and immunostimulatory system comprising an oxidoreductase enzyme |
| 01/23/2014 | US20140023591 Heteromultivalent nanoparticle compositions |
| 01/23/2014 | CA2876787A1 Inhibitors of the cd95 signaling pathway for treatment of mds |
| 01/22/2014 | EP2687541A1 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
| 01/22/2014 | EP2687540A1 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
| 01/22/2014 | EP2687539A1 Annexin v variant, and preparation and use thereof |
| 01/22/2014 | EP2687537A1 Polypeptide drug against hepatitis b virus x protein |
| 01/22/2014 | EP2687264A1 Macrophage Activating Factor for treatment of endometriosis |
| 01/22/2014 | EP2687231A1 Composition for treatment and diagnosis of pancreatic cancer |
| 01/22/2014 | EP2687225A1 HIP/PAP protein and derivatives thereof for use in treating cancer |
| 01/22/2014 | EP2687224A1 Medicament for wound treatment |
| 01/22/2014 | EP2687223A1 Detecting and treating dementia |
| 01/22/2014 | EP2687219A1 Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions |
| 01/22/2014 | EP2687216A2 Pharmaceutical composition for treating aging-associated diseases, containing progerin expression inhibitor as active ingredient, and screening method of said progerin expression inhibitor |
| 01/22/2014 | EP2687209A1 Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor |
| 01/22/2014 | EP2687206A1 Targeting of EWS-FLI1 as anti-tumor therapy |
| 01/22/2014 | EP2686431A1 Antagonists of the interleukin- 1 receptor |
| 01/22/2014 | EP2686337A1 Oligopeptides and process for preparation thereof |
| 01/22/2014 | EP2686007A2 Methods of diagnosing and treating vascular associated maculopathy and symptoms thereof |
| 01/22/2014 | EP2686006A1 Composition comprising diamine oxidase for the prevention of hangover symptoms |
| 01/22/2014 | EP2686005A1 Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain |
| 01/22/2014 | EP2686004A1 Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome |
| 01/22/2014 | EP2686003A2 Human insulin analogues and derivatives comprising cysteine substitutions |
| 01/22/2014 | EP2686002A1 Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen |
| 01/22/2014 | EP2686001A1 Uses of modified elr-cxc chemokine g31p to treat cancer |
| 01/22/2014 | EP2686000A1 Multiplexed detection with isotope-coded reporters |
| 01/22/2014 | EP2685999A2 Peptides for suppressing inflammation |
| 01/22/2014 | EP2685995A1 Yeast-brachyury immunotherapeutic compositions |
| 01/22/2014 | EP2685974A2 Inhibition and treatment of biofilms |
| 01/22/2014 | EP2685963A2 Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control |
| 01/22/2014 | EP2685841A1 Functional foods comprising diamine oxidase and uses thereof |
| 01/22/2014 | CN1890264B Gag binding proteins |
| 01/22/2014 | CN103534349A Polypeptides having endopeptidase activity and polynucleotides encoding same |
| 01/22/2014 | CN103534265A Cyclic peptides with an anti-neoplasic and anti-angiogenic activity |
| 01/22/2014 | CN103533952A Human insulin analogues and derivatives comprising cysteine substitutions |
| 01/22/2014 | CN103533951A Method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (GDF-15) |
| 01/22/2014 | CN103533950A Use of a vegf antagonist to treat angiogenic eye disorders |
| 01/22/2014 | CN103533949A High-affinity, dimeric inhibitors of psd-95 as efficient neuroprotectants against ischemic brain damage and for treatment of pain |
| 01/22/2014 | CN103533928A Treatment of disorders with altered vascular barrier function |
| 01/22/2014 | CN103525941A Application of CTHRC1 genes in preparation of drugs for detecting/treating cervical cancer |
| 01/22/2014 | CN103525824A Octopusochellatus serine protease inhibitor OoSerpin gene and recombinant protein and application thereof |
| 01/22/2014 | CN103524628A Recombinant ganoderma lucidum immunoregulatory protein, human serum albumin fusion protein, and preparation method and application thereof |
| 01/22/2014 | CN103524627A Double-target-spot fusion protein capable of enhancing TRAIL antitumor activity |
| 01/22/2014 | CN103524626A Recombinant double-target protein medicine and application thereof |
| 01/22/2014 | CN103524602A Application of antibacterial peptide in pharmacy |
| 01/22/2014 | CN103524600A New cyclic lipopeptides locillomycin A, B and C and preparation method thereof |
| 01/22/2014 | CN103524599A Cyclopeptide luteinizing hormone releasing hormone (LHRH) antagonist derivatives and pharmaceutical use thereof |
| 01/22/2014 | CN103524598A Cyclic peptide compound and preparation method thereof as well as medicinal composition and application thereof |
| 01/22/2014 | CN103520735A Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| 01/22/2014 | CN103520724A Novel application of inhibitor for protein HSD17B13 or coding genes thereof |
| 01/22/2014 | CN103520711A Formula composition and medicinal preparation with effects of increasing bone density and treating bone joint pain, preparation method of medicinal preparation and application of formula composition |
| 01/22/2014 | CN103520710A Medicament |
| 01/22/2014 | CN103520709A Regulation and control method for fish protein absorption related factors |
| 01/22/2014 | CN103520708A Composition capable of promoting wound healing and reducing scarring |
| 01/22/2014 | CN103520707A Probiotic and bacteria-treating composition for preventing and treating infection of reproductive system |
| 01/22/2014 | CN103520706A Oral recombined human serum albumin fusion protein preparation formula, products of the protein preparation, and applications of the protein preparation |
| 01/22/2014 | CN103520705A Application of CD226 extracellular domain protein in inhibition of tumor cell proliferation |
| 01/22/2014 | CN103520704A Application of lampetra japonica genetic recombinant protein rLj-RGD3 in preparation of cerebral ischemia reperfusion protective medicament |
| 01/22/2014 | CN103520703A Application of eIF6 in detection, prevention or treatment of exercise-induced fatigue or memory loss |
| 01/22/2014 | CN103520702A Cow udder cleaning agent used for preventing bovine mastitis |
| 01/22/2014 | CN103520701A Application of A type botulinum toxin in preparation of medicine for preventing neuropathic pains before operation |
| 01/22/2014 | CN103520700A Biotechnological production of cyanophycin dipeptides |
| 01/22/2014 | CN103520699A Veterinary traditional Chinese medicine antiviral injection and preparation method thereof |
| 01/22/2014 | CN103520215A Functional antibacterial peptide protein preparation for effectively treating cad pigs and using method thereof |